A POLITICO report examines the growing political support for psychedelic research within parts of the Republican Party, particularly around treatments for veterans experiencing PTSD and other mental health challenges. Health and Human Services Secretary Robert F. Kennedy Jr. has signaled interest in expanding clinical studies into psychedelic-assisted therapies, reflecting a broader shift in the national conversation about alternative approaches to mental health care.
The article also highlights state-level initiatives advancing this research, including Texas’ $50 million investment in clinical trials for ibogaine. Advocates such as former Texas Governor Rick Perry and Americans for Ibogaine CEO Bryan Hubbard argue that increased research could help evaluate new treatment options for addiction, trauma, and related conditions, while scientists and regulators emphasize the importance of rigorous clinical trials to assess safety and effectiveness.